The Hidden Money in Your Health Plan: Rebates, Spreads, and the New Rules That Expose Them
Every CFO wants the same thing from a health plan: predictable costs, measurable value, and confidence that every dollar is working for the company and its employees.
Yet many employers still cannot answer a basic question: What happens to the money generated by our prescription volume?
The answer may include manufacturer rebates, pharmacy discounts, administrative payments, and pricing spreads that never appear clearly in your plan reports. A plan may receive a headline guarantee such as “100% rebate pass-through” while significant value remains outside the definition of “rebate.”
That is changing.
New federal requirements are moving the market toward drug-level reporting, broader disclosure, and 100% pass-through of rebates and related remuneration for eligible employer plans. For calendar-year plans, many of these requirements begin in 2029: but the contracting decisions that determine whether your organization captures that value are happening now.
For CFOs, HR leaders, and benefits consultants, the conclusion is direct: if your pharmacy arrangement is not transparent today, your company may be leaving money on the table today.
The money is there: but your reports may not show it
Prescription spending creates several potential revenue streams. Traditional arrangements often combine those streams into a single invoice or high-level report, leaving plan sponsors unable to see the economics behind each drug.
Three areas deserve immediate attention.
Retained rebates
Manufacturers may provide rebates or other price concessions tied to formulary placement, utilization, market share, or performance. If your employees use the product, your plan may help generate that payment.
But a summary report showing “total rebates received” does not tell you:
Which drugs generated the payments
How much was collected before fees or other deductions
What was retained by an administrator or affiliate
Whether the plan received all remuneration connected to its utilization
Aggregate reporting makes verification nearly impossible. You may know that money came back. You may not know whether you received all of it.
Spread pricing
Spread pricing is simple in concept.
A plan is charged $100 for a prescription. The pharmacy receives $60. The $40 difference is retained as margin.
If your contract and reporting do not show both sides of that transaction, you see only the $100 charge. The spread remains invisible.
That structure can make a low administrative fee appear attractive while the real compensation sits inside drug pricing. A transparent pharmacy model replaces that uncertainty with a clearly defined administrative fee and a direct view of what the pharmacy was paid.
Hidden markups and alternative fees
Manufacturer payments do not always appear under the word “rebate.” They may be described as administrative fees, data fees, consulting payments, performance payments, price-protection payments, or other forms of remuneration.
This is why the phrase “100% rebate pass-through” requires scrutiny.
The critical question is not simply, “Do you pass through 100% of rebates?”
It is: “How does the contract define every payment connected to our members’ drug utilization: and what, exactly, can be retained?”
“100% pass-through” only works when 100% means everything
A narrow definition can make a contract sound transparent without making it economically transparent.
For example, an agreement may pass through 100% of manufacturer rebates but exclude payments collected by an affiliated organization, certain discounts negotiated upstream, or fees that are not technically labeled rebates. The plan receives 100% of the defined amount: but not necessarily 100% of the value generated by its utilization.
The new rules address this problem by expanding the focus beyond traditional rebates.
Under the Consolidated Appropriations Act, 2026, eligible ERISA-covered group health plans are expected to receive 100% of rebates, fees, alternative discounts, and other remuneration tied to drug utilization or spending, excluding legitimate, clearly defined service fees. The law also establishes more detailed reporting and audit expectations.
For most calendar-year plans, the core requirements apply beginning January 1, 2029. Non-calendar-year plans may reach the implementation date sooner, depending on their plan year and contract cycle.
That deadline may seem distant. It is not.
Pharmacy contracts are negotiated, renewed, and extended well before a plan year begins. A contract signed today can determine whether your organization has the data, definitions, and protections it needs when the rules take effect.
Drug-level disclosure turns opacity into accountability
A high-level annual report is not enough to manage pharmacy spend strategically.
CFOs need to understand net cost: not just gross spend or rebate totals. HR leaders need confidence that plan design decisions are improving affordability for employees. Benefits consultants need reliable data to compare arrangements based on actual economics rather than marketing language.
Drug-level reporting should make it possible to evaluate:
Ingredient cost and total plan payment
Pharmacy reimbursement
Member out-of-pocket cost
Rebates and other manufacturer remuneration
Amounts retained by administrators or affiliates
Spread pricing or channel differentials
Formulary placement and utilization
Use of affiliated pharmacies
Administrative fees and other compensation
This level of visibility changes the conversation. Instead of asking whether a plan received a large rebate, you can ask whether the plan achieved the lowest appropriate net cost for each drug category.
It also helps expose conflicts that aggregate reporting conceals. A drug with a larger rebate is not automatically the best financial choice if its total net cost remains higher than an alternative.
Transparency gives plan sponsors control. Control creates better decisions. Better decisions create lasting savings.
Quilt makes transparency operational: not theoretical
Quilt Benefits is an independent third-party administrator (TPA), not a benefits broker. That means no insurance sales, no commissions, and no conflict of interest baked into your plan. We build and run self-funded health plans for CFOs and HR leaders, while your broker stays on as your independent advisor. We administer the plan; they keep advising you.
Quilt built its model around a straightforward principle: your health plan should work for your organization, not for hidden revenue streams.
Our transparent pharmacy model is designed to provide 100% rebate pass-through, clear compensation, and the visibility employers need to evaluate true net cost. We partner with CFOs, HR teams, and benefits consultants to bring structure and accountability to one of the most complex areas of healthcare spending.
That transparency works within a broader self-funded strategy.
Because Quilt administers the plan end to end, we see 100% of your data — and we act on all of it through one integrated process covering five cost levers:
Pharmacy transparency — the rebates, spreads, and hidden fees described above, exposed and recaptured.
High-cost specialty drugs — the fastest-growing line item in most plans, managed through clinical review and sourcing strategy.
GLP-1s — a disciplined approach to a drug class that can otherwise dominate trend.
Large claim management — the few members who drive a disproportionate share of spend, supported proactively. Quilt reports 48% savings on large claimants; results vary by employer and no savings figure is guaranteed.
Stop loss management — contracting and thresholds that actually protect the plan you designed.
One integrated process, typically recapturing around 30% of benefits spend. And because access to competitive national provider networks is a must-have, your employees keep that access too — it's table stakes, not the story.
The result is a plan built around your workforce rather than a standardized arrangement designed for someone else.
Employers can also use Quilt’s Cost Containment Marketplace to evaluate pre-certified solutions without adding unnecessary administrative complexity. The objective is not to cut benefits indiscriminately. It is to remove waste, direct care more effectively, and preserve value for employees.
Our clients can pursue up to 30% savings potential, while targeted strategies have produced 48% savings on large claimants. Those outcomes come from acting on 100% of your data across all five cost levers — coordinated plan design, analytics, cost containment, and transparent financial controls: not from relying on one rebate number.
Read more about how self-funded plans put your company first and how transparency replaces hidden markups with real savings.
Your 2026 contract should anticipate 2029
Waiting for regulations to force transparency is a costly strategy. Employers can negotiate for the protections now.
Your next pharmacy agreement should address five questions clearly:
Benefits consultants should help clients evaluate proposals on total net cost and fiduciary defensibility: not on the size of a headline rebate alone.
HR leaders should ask whether employees are benefiting from the value their prescriptions generate. CFOs should ask whether current reports provide enough information to budget, forecast, and challenge renewal assumptions.
The answers should be specific. “That information is proprietary” is not a transparency strategy.
The hidden money is your money
The market is moving toward disclosure because employers can no longer afford to manage pharmacy spend through blind trust.
New rules will expose more of the money moving through prescription arrangements. But disclosure alone will not guarantee savings. Employers still need contracts that define remuneration correctly, prohibit hidden spreads, require timely pass-through, and provide drug-level data.
Quilt Benefits delivers that structure through a transparent pharmacy model integrated with a modern, self-funded benefits platform. We partner with CFOs seeking control, HR teams seeking simplicity, and employees who deserve benefits that deliver real value.
Your organization may be leaving money on the table right now. The next contract is your opportunity to bring it back into the plan: and put your company in full control of the dollars your workforce generates.
Curious what your plan could save?
Tired of high renewal costs and hidden plan economics with no data visibility? Wondering whether fully insured, level-funded, self-funded, or reference-based pricing is actually the right fit for your company? Unlock the Quilt Benefits Employee Benefits Guide & Calculator: enter your details and generate a custom 3-year savings report for your plan in minutes.